RESUMEN
It was found that the diterpene alkaloid songorine administered per os to mice at a dose of 25 µg/kg provides a pronounced anxiolytic effect during elevated plus maze testing comparable to the effect of the benzodiazepine anxiolytic phenazepam. Recording of ultrasonic vocalizations of animals revealed an increase in the number of short high-frequency (50 kHz) signals under the action of songorine and the reference drug, which confirms their anti-anxiety properties.
Asunto(s)
Ansiolíticos , Vocalización Animal , Animales , Ansiolíticos/farmacología , Ratones , Vocalización Animal/efectos de los fármacos , Masculino , Ansiedad/tratamiento farmacológico , Aprendizaje por Laberinto/efectos de los fármacos , Diterpenos/farmacología , Benzodiazepinas/farmacología , Prueba de Laberinto Elevado , Conducta Animal/efectos de los fármacos , Ultrasonido , AlcaloidesRESUMEN
We performed a comparative in vitro study of the involvement of NF-κB, PI3K, cAMP, ERK1/2, p38, JAKs, STAT3, JNK, and p53-dependent intracellular signaling in the functioning of neural stem cells (NSC) under the influence of basic fibroblast growth factor (FGF) and FGF receptor agonist, diterpene alkaloid songorine. The significant differences in FGFR-mediated intracellular signaling in NSC were revealed for these ligands. In both cases, stimulation of progenitor cell proliferation occurs with the participation of NF-κB, PI3K, ERK1/2, JAKs, and STAT3, while JNK and p53, on the contrary, inhibit cell cycle progression. However, under the influence of songorin, cAMP- and p38-mediated cascades are additionally involved in the transmission of the NSC division-activating signal. In addition, unlike FGF, the alkaloid stimulates progenitor cell differentiation by activating ERK1/2, p38, JNK, p53, and STAT3.
Asunto(s)
Diferenciación Celular , Proliferación Celular , Diterpenos , Células-Madre Neurales , Receptores de Factores de Crecimiento de Fibroblastos , Factor de Transcripción STAT3 , Transducción de Señal , Células-Madre Neurales/efectos de los fármacos , Células-Madre Neurales/metabolismo , Células-Madre Neurales/citología , Animales , Factor de Transcripción STAT3/metabolismo , Receptores de Factores de Crecimiento de Fibroblastos/metabolismo , Receptores de Factores de Crecimiento de Fibroblastos/agonistas , Transducción de Señal/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Diterpenos/farmacología , Diferenciación Celular/efectos de los fármacos , FN-kappa B/metabolismo , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Factor 2 de Crecimiento de Fibroblastos/farmacología , Proteína p53 Supresora de Tumor/metabolismo , Proteína p53 Supresora de Tumor/agonistas , Fosfatidilinositol 3-Quinasas/metabolismo , Alcaloides/farmacología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Quinasas Janus/metabolismo , AMP Cíclico/metabolismo , Células Cultivadas , RatasRESUMEN
Analysis of specific pharmacological activity evaluated high antinociceptive efficacy of the first synthesized compound 10-di(ethoxyacetyl)-2,6,8,12-tetraacetyl-2,4,6,8,10,12-hexaazatetracyclo[5,5,0,03,11,05,9]dodecane (ethowurtzine) in models of somatogenic pain of different genesis (thermal, visceral pain, mechanical compression of paw).The new molecule from the class of hexaazaisowurtzitane effectively blocks nociceptive reactions at the supraspinal and peripheral levels of pain sensitivity organization. The effect of ethowurtzine was comparable or exceeded the effect of tramadol. The obtained results prove the possibility of creating new pharmacologically active molecules based on the high-energy substance hexaazaisowurtzitane.
Asunto(s)
Dolor , Tramadol , Humanos , Dimensión del Dolor/métodos , Dolor/tratamiento farmacológico , Tramadol/farmacología , Tramadol/uso terapéutico , Umbral del Dolor , Analgésicos/farmacología , Analgésicos/uso terapéutico , Analgésicos Opioides/farmacologíaRESUMEN
Using rat and mouse models of neurogenic, ethanol-induced, and indometacin-induced damage to the gastric mucosa we demonstrated that course preventive treatment with flavonoid complex from aerial parts of Lychnis chalcedonica L. increased the resistance of gastric mucosa to ulcerogenic factors of different etiology. The gastroprotective effect of the phytocomplex in a dose range of 16-1600 µg/kg was comparable with that of the reference drug plantaglucide and was superior to that of the reference drugs eleutherococcus extract and methyluracil in the therapeutic doses. The antiulcerogenic activity of Lychnis chalcedonica flavonoid complex considerably exceeded activity of Lychnis chalcedonica L. extract demonstrated in our previous experiments.
Asunto(s)
Antiulcerosos/uso terapéutico , Extractos Vegetales/uso terapéutico , Úlcera Gástrica/tratamiento farmacológico , Animales , Animales no Consanguíneos , Antiulcerosos/aislamiento & purificación , Antiulcerosos/farmacología , Citoprotección/efectos de los fármacos , Modelos Animales de Enfermedad , Etanol , Flavonoides/aislamiento & purificación , Flavonoides/farmacología , Flavonoides/uso terapéutico , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/patología , Indometacina , Lychnis/química , Masculino , Ratones , Inflamación Neurogénica/tratamiento farmacológico , Inflamación Neurogénica/patología , Fitoterapia , Extractos Vegetales/farmacología , Ratas , Ratas Wistar , Silene , Úlcera Gástrica/inducido químicamente , Úlcera Gástrica/patologíaRESUMEN
The use of lithium drugs in clinical practice requires constant monitoring of lithium plasma concentration, because toxicity is sometimes observed at therapeutic concentrations of lithium. This is often associated with fluctuations of plasma concentration of lithium ions after intake of individual doses. Therefore, the use of a porous carrier providing a stable blood level of the drug is extremely promising and important for clinical practice. We studied activity of a new lithium drug (lithium complex) consisting of aluminum-silicon base and lithium citrate immobilized on its surface. Lithium carbonate served as the reference drug. It was shown that lithium carbonate and lithium complex exhibited no anxiolytic activity in the conflict model, but produced an antidepressant effect and improved exploratory behavior of animals.
Asunto(s)
Litio/farmacología , Siliconas/química , Óxido de Aluminio/química , Óxido de Aluminio/farmacología , Animales , Ansiolíticos/farmacología , Conducta Exploratoria/efectos de los fármacos , Carbonato de Litio/química , Carbonato de Litio/farmacología , Masculino , RatonesRESUMEN
Possible involvement of µ1- and κ-opioid receptors and cannabinoid type 1 receptors (CB1) into the mechanism of analgesic activity of the experimental drug product "Thiowurtzine, (capsule 120 mg)" synthesized on the basis of active pharmaceutical substance 4-(3,4-dibromthiophencarbonyl)-2,6,8,12-tetraacethyl-2,4,6,8,10,12hexaazatetracyclo [5,5,0,03,11,05,9]dodecane was studied in vivo using the hot plate test and acetic acid writhing test. The involvement of κ-opioid receptors and noninvolvement of µ1-receptors and CB1 receptors in the mechanism of thiowurtzine analgesia were demonstrated. The mechanism of interaction of the test analgesic with opioid receptors differs from that of the reference drug tramadol. The interaction of thiowurtzine with serotonergic, GABAergic, and muscarinic cholinergic neurotransmitter systems was studied in vivo using pharmacological analyzers. The absence of muscarinic cholinolytic effect of thiowurtzine was demonstrated in the model of arecoline-induced tremor. The central serotonin-blocking activity of the analgesic was revealed in the model of 5-hydroxytryptophan hyperkinesis in mice. Anticonvulsant activity was demonstrated in the corazol convulsions test, which attested to the presence of a GABAergic component. The mechanism of central analgesia caused by the drug product "Thiowurtzine, capsule 120 mg" appeared to be polymodal. The antinociceptive activity of the analgesic was comparable to that of tramadol.
Asunto(s)
Neurotransmisores/metabolismo , Receptores Opioides/metabolismo , Analgésicos , Animales , Sistema Nervioso Central/metabolismo , Modelos Animales de Enfermedad , Masculino , Ratones , Dimensión del Dolor , Receptor Cannabinoide CB1/metabolismo , Receptores Opioides kappa/metabolismoRESUMEN
Pronounced analgesic activity of the innovative compound 4-(3,4-dibromthiophencarbonyl)-2,6,8,12-tetraacethyl-2,4,6,8,10,12hexaazatetracyclo[5,5,0,03, 11,05, 9] dodecane (thiowurtzine) was observed in the thermal nociceptive hot plate test and in the acute visceral and somatic deep pain model (acetic acid writhing test). In these experimental models, naloxone-sensitive thiowurtzine-induced analgesia was revealed. The absence of tropism to peripheral opioid receptors in the acetic acid writhing test was demonstrated using naloxone methiodide. Course administration of low-toxic thiowurtzine in effective doses was not associated with ulcerogenic damage to the gastric mucosa in experimental animals.
Asunto(s)
Analgésicos/uso terapéutico , Dolor/tratamiento farmacológico , Animales , Modelos Animales de Enfermedad , Mucosa Gástrica/efectos de los fármacos , Masculino , Ratones , Naloxona/uso terapéutico , Dolor/fisiopatología , Dimensión del Dolor/métodosRESUMEN
Repeated administration of songorine to mice restored mnestic processes impaired by scopolamine treatment, which manifested in improvement of CPAR conditioning and normalization of behavioral activity throughtout the observation period. This thearpeutical effect surpassed that of pyracetam used as the reference drug.
Asunto(s)
Alcaloides/farmacología , Diterpenos/farmacología , Aconitum/química , Animales , Conducta Animal/efectos de los fármacos , Masculino , Ratones , Escopolamina/farmacologíaRESUMEN
The study examined the effects of a novel neurotropic medication based on a lithium complex composed of lithium citrate, polymethylsiloxane, and aluminum oxide on electrophysiological parameters of the rat brain. In contrast to lithium carbonate (the reference drug), the novel preparation resulted in a wave-like dynamics of electrical activity in the visual cortex. Rhythmic photic stimulation of the rats treated with lithium carbonate resulted in appearance of the signs attesting to up-regulation of excitability of cerebral cortex in all examined ranges. In contrast, the complex lithium preparation diminished the delta power spectrum, which was the only affected frequency band. It is hypothesized that the complex lithium medication induces milder activation of the cerebral cortex in comparison with lithium carbonate. The novel medication composed of lithium citrate, aluminum oxide, and polymethylsiloxane, is characterized by greater efficacy and safety than the preparation based on inorganic lithium salt (lithium carbonate).
Asunto(s)
Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Litio/farmacología , Óxido de Aluminio/farmacología , Animales , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Citratos/farmacología , Fenómenos Electrofisiológicos/efectos de los fármacos , Litio/química , Carbonato de Litio/farmacología , Masculino , Ratas , Siliconas/farmacologíaRESUMEN
Anti-inflammatory and analgesic activities of the complex of flavonoids from Lychnis chalcedonica L. were studied in the models of acute aseptic inflammation induced by carrageenan, histamine, and serotonin and acetic acid-induced painful chemical stimulation. It is demonstrated that course treatment with flavonoids derived from Lychnis chalcedonica L. produced a stable pharmacological effect comparable with that of the reference anti-inflammatory drug diclofenac.
Asunto(s)
Analgésicos/uso terapéutico , Antiinflamatorios/uso terapéutico , Carragenina/toxicidad , Flavonoides/uso terapéutico , Inflamación/tratamiento farmacológico , Lychnis/química , Ácido Acético/toxicidad , Animales , Diclofenaco/uso terapéutico , Femenino , Histamina/toxicidad , Inflamación/inducido químicamente , Masculino , Ratones , Serotonina/toxicidadRESUMEN
Psychopharmacological effects of JNK inhibitor were studied using a mouse model of posthypoxic encephalopathy. The preparation exhibited a pronounced cerebroprotective effect manifested in normalization of orientation and exploratory behavior and conditioned responses in posthypoxic mice. These effects were accompanied by marked elevation of neural stem cell content in the paraventricular region of the brain.
Asunto(s)
Encefalopatías/tratamiento farmacológico , Proteínas Quinasas JNK Activadas por Mitógenos/antagonistas & inhibidores , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Animales , Antracenos/farmacología , Antracenos/uso terapéutico , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Encefalopatías/psicología , Conducta Exploratoria/efectos de los fármacos , Masculino , Ratones , Células-Madre Neurales/efectos de los fármacos , Medicina RegenerativaRESUMEN
Psychopharmacological effects of atisine-type diterpene alkaloid Z77 were studied under conditions of experimental posthypoxic encephalopathy. The preparation had a pronounced cerebroprotective effect consisting in normalization of orientation and exploratory behavior and conditioned activity in experimental animals. These changes were accompanied by significant increase in the number of neural stem cells in the paraventricular region of the brain and markedly enhanced production of neurotrophic growth factors by neural tissue microenvironment cells.
Asunto(s)
Alcaloides/farmacología , Alcaloides/uso terapéutico , Encefalopatías/tratamiento farmacológico , Animales , Encéfalo/efectos de los fármacos , Conducta Exploratoria/efectos de los fármacos , Masculino , Ratones , Células-Madre Neurales/efectos de los fármacos , Medicina RegenerativaRESUMEN
The effects of the extracts of the aboveground parts of Filipendula vulgaris Moench on the behavior and memory of mice after hypoxic injury and their physical performance in the open-field test were studied using the models of hypoxia in a sealed volume, conditioned passive avoidance response (CPAR), and forced swimming with a load. The extracts improved animal resistance to hypoxia, normalized orientation and exploration activities, promoted CPAR retention after hypoxic injury, and increased physical performance. Aqueous extract of meadowsweet had the most pronounced effect that corresponded to the effect of the reference drug piracetam. These effects were probably caused by modulation of hippocampal activity.
Asunto(s)
Filipendula/química , Nootrópicos/química , Nootrópicos/farmacología , Extractos Vegetales/química , Extractos Vegetales/farmacología , Animales , Reacción de Prevención/efectos de los fármacos , Masculino , Ratones , Piracetam/farmacologíaRESUMEN
Nootropic activity of water extract fractions from aerial parts of Filipendula vulgaris Moench was demonstrated on the models of hermetic volume hypoxia, conditioned passive avoidance response, open field test, and forced swimming with a load. The fractions stimulated hypoxic resistance, normalized orientation and exploratory behavior, improved conditioned response reproduction during testing after hypoxic injury, and increased exercise tolerance. Fractionation of the extract led to dissociation of the effect components, which suggests that individual constituents have specific characteristics. Ethylacetate fraction exhibited most pronounced nootropic activity and was superior to plant extract by some characteristics. The detected effects seemed to be caused by modulation of the hippocampus activity the under the effects of phenol and triterpene compounds.
Asunto(s)
Filipendula/química , Nootrópicos/farmacología , Extractos Vegetales/química , Agua/química , Animales , Conducta Exploratoria/efectos de los fármacos , Masculino , Ratones , Nootrópicos/química , Componentes Aéreos de las Plantas/químicaRESUMEN
Injection of 5-fluorouracil to animals caused a pronounced toxic effect. Therapeutic and preventive treatment with Salix viminalis leaf extract significantly reduced the negative effects of the antitumor drug: promoted recovery of the bone marrow, peripheral blood, and visceral parameters and prevented ulceration. Combined use of the cytostatic and Salix viminalis extract increased the efficiency of antitumor therapy.
Asunto(s)
Antimetabolitos Antineoplásicos/toxicidad , Fluorouracilo/toxicidad , Fitoterapia , Extractos Vegetales/uso terapéutico , Salix/química , Animales , Antimetabolitos Antineoplásicos/uso terapéutico , Recuento de Células Sanguíneas , Médula Ósea/efectos de los fármacos , Carcinoma Pulmonar de Lewis/tratamiento farmacológico , Carcinoma Pulmonar de Lewis/secundario , Citostáticos/uso terapéutico , Citostáticos/toxicidad , Evaluación Preclínica de Medicamentos , Etanol , Fluorouracilo/uso terapéutico , Enfermedades Hematológicas/inducido químicamente , Enfermedades Hematológicas/prevención & control , Hematopoyesis/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Extractos Vegetales/farmacología , Hojas de la Planta/química , Solventes , Esplenomegalia/inducido químicamente , Esplenomegalia/prevención & control , Úlcera Gástrica/inducido químicamente , Úlcera Gástrica/prevención & control , Vísceras/efectos de los fármacosRESUMEN
The anxiolytic and antidepressant activities of complex preparations divaza and brizantin containing antibodies to brain-specific protein S100 were estimated using Vogel conflict test and Nomura forced swimming test. Course treatment (5 days) of brizantin in a dose of 2.5 ml/kg and divaza in a dose of 7.5 ml/kg significantly increased punished drinking in the Vogel conflict test in comparison with the control. Both drugs also improved general emotional behavior during training prior to the test procedure. Brizantin and divaza in a dose of 7.5 ml/kg increased the number of wheel revolutions in the Nomura forced swimming test in comparison with the control; the effect of divaza was more pronounced. High correlation coefficients between the number of wheel revolutions during the first and second 5-min sessions are also indicative of antidepressant action of divaza and brizantin.
Asunto(s)
Ansiolíticos/farmacología , Anticuerpos/farmacología , Antidepresivos/farmacología , Animales , Conducta Animal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Diazepam/farmacología , Combinación de Medicamentos , Evaluación Preclínica de Medicamentos , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Ratas , Estrés Psicológico/patología , Natación/psicologíaRESUMEN
Antianxiety action of diterpene alkaloid songorine was studied using Vogel conflict test. Songorine in a dose of 0.25 mg/kg demonstrated high anxiolytic activity comparable to that of phenazepam and produced no sedative effect.
Asunto(s)
Alcaloides/farmacología , Ansiolíticos/farmacología , Diterpenos/farmacología , Estrés Psicológico/tratamiento farmacológico , Aconitum/química , Alcaloides/aislamiento & purificación , Animales , Ansiolíticos/aislamiento & purificación , Conducta Animal/efectos de los fármacos , Benzodiazepinas/farmacología , Conflicto Psicológico , Diterpenos/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Masculino , Ratones , Ratones Endogámicos CBA , Estrés Psicológico/fisiopatologíaRESUMEN
The role of cAMP- and IKK-2-dependent pathways in stimulation of the growth capacity of mesenchymal progenitor cells with alkaloid songorine was studied in vitro. Inhibitors of adenylate cyclase and IKK-2 were shown to abolish the increase in proliferative activity of progenitor cells. Moreover, blockade of the inhibitory kinase complex was accompanied by a decrease in the intensity of progenitor cell differentiation.
Asunto(s)
Adenilil Ciclasas/genética , Alcaloides/farmacología , AMP Cíclico/metabolismo , Quinasa I-kappa B/genética , Células Madre Mesenquimatosas/efectos de los fármacos , Adenilil Ciclasas/metabolismo , Animales , Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , AMP Cíclico/antagonistas & inhibidores , Didesoxiadenosina/análogos & derivados , Didesoxiadenosina/farmacología , Inhibidores Enzimáticos/farmacología , Regulación de la Expresión Génica , Quinasa I-kappa B/antagonistas & inhibidores , Quinasa I-kappa B/metabolismo , Masculino , Células Madre Mesenquimatosas/citología , Células Madre Mesenquimatosas/metabolismo , Ratones , Ratones Endogámicos CBA , Cultivo Primario de Células , Transducción de Señal , Células Madre , Tiofenos/farmacologíaRESUMEN
We studied the psychopharmacological effects of atisine-type diterpene alkaloid Z77 in a rat model of cerebral ischemia. Pronounced cerebroprotective effect was found consisting in normalization of the orienting and exploratory activity and conditioned behavior associated with significant correction of morphological changes in the brain. The direct stimulatory effect of Z77 on neural stem cells was shown in vitro.
Asunto(s)
Alcaloides/uso terapéutico , Isquemia Encefálica/tratamiento farmacológico , Células-Madre Neurales/citología , Células-Madre Neurales/efectos de los fármacos , Fármacos Neuroprotectores/uso terapéutico , Animales , Masculino , Ratas , Medicina Regenerativa/métodosRESUMEN
We studied the psychopharmacological effects of atisine-type diterpene alkaloid Z77 in a rat model of brain ischemia in the morning and at night. The type of developing locomotor disorders in animals was shown to depend on circadian rhythms. Administration of Z77 substantially corrected manifestations of psychoneurological symptoms. The parameters of orientation and exploratory behavior and conditioned reflex activity were normalized. The key role of receptors of neural stem cells to fibroblast growth factor in the realization of their growth potential under the influence of the alkaloid was demonstrated. Under in vitro conditions, antibodies to fibroblast growth factor receptor abolished the increase in the number of neural CFU caused by Z77 in the culture of intact cells from the paraventricular region of the brain.